Literature DB >> 19748229

Novel immune response to gluten in individuals with schizophrenia.

Diana Samaroo1, Faith Dickerson, Donald D Kasarda, Peter H R Green, Chiara Briani, Robert H Yolken, Armin Alaedini.   

Abstract

A link between celiac disease and schizophrenia has been postulated for several years, based primarily on reports of elevated levels of antibody to gliadin in patients. We sought to examine the proposed connection between schizophrenia and celiac disease by characterizing the molecular specificity and mechanism of the anti-gliadin immune response in a subset of individuals with schizophrenia. Blood samples from individuals with schizophrenia and elevated anti-gliadin antibody titer were examined for celiac disease-associated biomarkers, including antibodies to transglutaminase 2 (TG2) enzyme and deamidated gliadin peptides, as well as the HLA-DQ2 and -DQ8 MHC genes. The anti-gliadin antibody response was further characterized through examination of reactivity towards chromatographically separated gluten proteins. Target proteins of interest were identified by peptide mass mapping. In contrast to celiac disease patients, an association between the anti-gliadin immune response and anti-TG2 antibody or HLA-DQ2 and -DQ8 markers was not found in individuals with schizophrenia. In addition, the majority of individuals with schizophrenia and anti-gliadin antibody did not exhibit antibody reactivity to deamidated gliadin peptides. Further characterization of the antibody specificity revealed preferential reactivity towards different gluten proteins in the schizophrenia and celiac disease groups. These findings indicate that the anti-gliadin immune response in schizophrenia has a different antigenic specificity from that in celiac disease and is independent of the action of transglutaminase enzyme and HLA-DQ2/DQ8. Meanwhile, the presence of elevated levels of antibodies to specific gluten proteins points to shared immunologic abnormalities in a subset of schizophrenia patients. Further characterization and understanding of the immune response to gluten in schizophrenia may provide novel insights into the etiopathogenesis of specific disease phenotypes. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748229      PMCID: PMC2856786          DOI: 10.1016/j.schres.2009.08.009

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  42 in total

1.  Celiac syndrome in the case histories of five schizophrenics.

Authors:  H GRAFF; A HANDFORD
Journal:  Psychiatr Q       Date:  1961-04

2.  Childhood schizophrenia.

Authors:  L BENDER
Journal:  Psychiatr Q       Date:  1953-10

3.  Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia.

Authors:  J Wei; Gwynneth P Hemmings
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

4.  Immune involvement in schizophrenia and autism: etiology, pathology and animal models.

Authors:  Paul H Patterson
Journal:  Behav Brain Res       Date:  2008-12-24       Impact factor: 3.332

5.  Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.

Authors:  Brian H Shirts; Konasale M Prasad; Michael F Pogue-Geile; Faith Dickerson; Robert H Yolken; Vishwajit L Nimgaonkar
Journal:  Schizophr Res       Date:  2008-09-17       Impact factor: 4.939

6.  Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.

Authors:  Nicola G Cascella; Debra Kryszak; Bushra Bhatti; Patricia Gregory; Deanna L Kelly; Joseph P Mc Evoy; Alessio Fasano; William W Eaton
Journal:  Schizophr Bull       Date:  2009-06-03       Impact factor: 9.306

7.  Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia.

Authors:  M Hadjivassiliou; R A Grünewald; A K Chattopadhyay; G A Davies-Jones; A Gibson; J A Jarratt; R H Kandler; A Lobo; T Powell; C M Smith
Journal:  Lancet       Date:  1998-11-14       Impact factor: 79.321

8.  Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease.

Authors:  Elke Schwertz; Franka Kahlenberg; Ulrich Sack; Thomas Richter; Martin Stern; Karsten Conrad; Klaus-Peter Zimmer; Thomas Mothes
Journal:  Clin Chem       Date:  2004-10-07       Impact factor: 8.327

9.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.

Authors:  Shaun M Purcell; Naomi R Wray; Jennifer L Stone; Peter M Visscher; Michael C O'Donovan; Patrick F Sullivan; Pamela Sklar
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

10.  Common variants conferring risk of schizophrenia.

Authors:  Hreinn Stefansson; Roel A Ophoff; Stacy Steinberg; Ole A Andreassen; Sven Cichon; Dan Rujescu; Thomas Werge; Olli P H Pietiläinen; Ole Mors; Preben B Mortensen; Engilbert Sigurdsson; Omar Gustafsson; Mette Nyegaard; Annamari Tuulio-Henriksson; Andres Ingason; Thomas Hansen; Jaana Suvisaari; Jouko Lonnqvist; Tiina Paunio; Anders D Børglum; Annette Hartmann; Anders Fink-Jensen; Merete Nordentoft; David Hougaard; Bent Norgaard-Pedersen; Yvonne Böttcher; Jes Olesen; René Breuer; Hans-Jürgen Möller; Ina Giegling; Henrik B Rasmussen; Sally Timm; Manuel Mattheisen; István Bitter; János M Réthelyi; Brynja B Magnusdottir; Thordur Sigmundsson; Pall Olason; Gisli Masson; Jeffrey R Gulcher; Magnus Haraldsson; Ragnheidur Fossdal; Thorgeir E Thorgeirsson; Unnur Thorsteinsdottir; Mirella Ruggeri; Sarah Tosato; Barbara Franke; Eric Strengman; Lambertus A Kiemeney; Ingrid Melle; Srdjan Djurovic; Lilia Abramova; Vasily Kaleda; Julio Sanjuan; Rosa de Frutos; Elvira Bramon; Evangelos Vassos; Gillian Fraser; Ulrich Ettinger; Marco Picchioni; Nicholas Walker; Timi Toulopoulou; Anna C Need; Dongliang Ge; Joeng Lim Yoon; Kevin V Shianna; Nelson B Freimer; Rita M Cantor; Robin Murray; Augustine Kong; Vera Golimbet; Angel Carracedo; Celso Arango; Javier Costas; Erik G Jönsson; Lars Terenius; Ingrid Agartz; Hannes Petursson; Markus M Nöthen; Marcella Rietschel; Paul M Matthews; Pierandrea Muglia; Leena Peltonen; David St Clair; David B Goldstein; Kari Stefansson; David A Collier
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

View more
  36 in total

1.  Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.

Authors:  Olaoluwa Okusaga; Dietmar Fuchs; Gloria Reeves; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Maureen Groer; Thomas B Cook; Kelly A Stearns-Yoder; Janardan P Pandey; Deanna L Kelly; Andrew J Hoisington; Christopher A Lowry; William W Eaton; Lisa A Brenner; Dan Rujescu; Teodor T Postolache
Journal:  Psychosom Med       Date:  2016-10       Impact factor: 4.312

2.  Gastrointestinal inflammation and associated immune activation in schizophrenia.

Authors:  Emily G Severance; Armin Alaedini; Shuojia Yang; Meredith Halling; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2012-03-24       Impact factor: 4.939

3.  Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Meredith Halling; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Didier Dupont; Faith B Dickerson; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2012-07-16       Impact factor: 5.996

4.  Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia.

Authors:  Jessica Jackson; William Eaton; Nicola Cascella; Alessio Fasano; Debby Santora; Kelli Sullivan; Stephanie Feldman; Heather Raley; Robert P McMahon; William T Carpenter; Haley Demyanovich; Deanna L Kelly
Journal:  Schizophr Res       Date:  2014-10-11       Impact factor: 4.939

5.  Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study.

Authors:  K Kridin; S Zelber-Sagi; D Comaneshter; A D Cohen
Journal:  Epidemiol Psychiatr Sci       Date:  2017-09-25       Impact factor: 6.892

6.  Search for schizophrenia susceptibility variants at the HLA-DRB1 locus among a British population.

Authors:  Lorna Halley; Mary K Doherty; Ian L Megson; Neil McNamara; Andy Gadja; Jun Wei
Journal:  Immunogenetics       Date:  2012-09-29       Impact factor: 2.846

7.  Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.

Authors:  Emily G Severance; Kristin L Gressitt; Shuojia Yang; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Faith B Dickerson; Robert H Yolken
Journal:  Bipolar Disord       Date:  2013-12-06       Impact factor: 6.744

8.  Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2013-06-06       Impact factor: 4.939

9.  Genome-wide genetic and transcriptomic investigation of variation in antibody response to dietary antigens.

Authors:  Rohina Rubicz; Robert Yolken; Armin Alaedini; Eugene Drigalenko; Jac C Charlesworth; Melanie A Carless; Emily G Severance; Bogdana Krivogorsky; Thomas D Dyer; Jack W Kent; Joanne E Curran; Matthew P Johnson; Shelley A Cole; Laura Almasy; Eric K Moses; John Blangero; Harald H H Göring
Journal:  Genet Epidemiol       Date:  2014-07       Impact factor: 2.135

Review 10.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.